Rhon-klinikum Ag · XETR:RHK
Rhon-klinikum — H1 2018 Earnings Presentation
10 slides from Rhon-klinikum's earnings presentation, Aug 2, 2018
Slide 1: First Half-Year Results 2018
First Half-Year Results 2018 2 August 2018 RHÖN-KLINIKUM AG - First Quarter 2017 Results - as of May 5, 2017 1
Slide 2: Disclaimer
Disclaimer This document has been prepared by RHÖN-KLINIKUM AG (“RHÖN-KLINIKUM” or “the Company”) for information purposes only, solely for use during this presentation. It must be treated confidentially by attendees at such presentation and must not be distributed, passed on or otherwise disclose
Slide 3: Highlights H1 2018
Highlights H1 2018 Against headwinds, solid economic development within first six months 432,317 inpatient and outpatient treatments (+2.2%) Revenues +3.6%/EBITDA +1.8%/net profit +4.1% Strategic focus on growth in new business areas: rollout of campus strategy, digitalization and telemedici
Slide 4: Key P&L figures First Half-Year of 2018
Key P&L figures First Half-Year of 2018 Operating performance on track despite adverse Performance1) vs. H1 2018 regulatory interventions and as yet unrecognized in € millions H1 2017 effects from separate accounting... Revenue 620.2 100.0% 3.6% o Attractive revenue growth of +3.6% incl. adjustments
Slide 5: Core balance sheet positions as of 30 June 2018
Core balance sheet positions as of 30 June 2018 €1,493m €1,493m 65.0% €970m Non-current assets €1,127m 75.5% Equity €523m 35.0% €17m Non-current liabilities 1.1% Current assets €348m Current liabilities 23.4% €178m cash Assets Equity & liabilities €178m cash assets Healthy and sustainable balance 75
Slide 6: Financial & regulatory outlook
Financial & regulatory outlook “We are paving the way to approach a double-digit EBITDA margin in the near future with our strategic vision including the expected effects from separate accounting” GUIDANCE FY 2018 Group revenues € 1.24bn +/- 5% fully Group EBITDA € 117.5m to € 127.5m confirmed Brief
Slide 7: Financial Calendar for FY 2018
Appendix Financial Calendar for FY 2018 23 February 2018 Preliminary results for financial year 2017 Conference call 29 March 2018 Publication of annual financial report 2017 Press conference 4 May 2018 Publication of interim report for the quarter ending 31 March 2018 6 June 2018 Annual Gen
Slide 8: Price Regulation in 2018 at a Glance
Appendix Price Regulation in 2018 at a Glance Average base rate increase in states with RHÖN hospitals Federal Total hospital system budget (weighted by RHÖN case mix) Level Wage sum increase as main reference number for RHÖN effective base rate Benchmark (wage sum) 1 DRG inflation in 2018: +2.97%
Slide 9: Shareholder base
Appendix Shareholder base Shareholder Structure as of 30 June 2018, according to the most recent notifications of voting rights at that time 25.1% Asklepios 26.7%1) 29.9% Free Float 70.1% 3.2% Strategic Landeskrankenhilfe Investors 5.4% 25.0% Ingeborg Münch B. Braun 14.6% Eugen Münch/HCM SE 1) Share
Slide 10: IR contact information
Appendix IR contact information Contact Julian Schmitt Head of Investor Relations & Treasury tel +49 9771 65 1536 email ir@rhoen-klinikum-ag.com RHÖN-KLINIKUM AG - Appendix 10